Pharming Group (PHAR) Competitors $8.00 -0.05 (-0.62%) As of 04/14/2025 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PHAR vs. TWST, HCM, MIRM, VCEL, BHC, BHVN, TARS, GMTX, AAPG, and BLTEShould you be buying Pharming Group stock or one of its competitors? The main competitors of Pharming Group include Twist Bioscience (TWST), HUTCHMED (HCM), Mirum Pharmaceuticals (MIRM), Vericel (VCEL), Bausch Health Companies (BHC), Biohaven (BHVN), Tarsus Pharmaceuticals (TARS), Gemini Therapeutics (GMTX), Ascentage Pharma Group International (AAPG), and Belite Bio (BLTE). These companies are all part of the "pharmaceutical products" industry. Pharming Group vs. Twist Bioscience HUTCHMED Mirum Pharmaceuticals Vericel Bausch Health Companies Biohaven Tarsus Pharmaceuticals Gemini Therapeutics Ascentage Pharma Group International Belite Bio Pharming Group (NASDAQ:PHAR) and Twist Bioscience (NASDAQ:TWST) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, community ranking, risk, media sentiment and profitability. Is PHAR or TWST more profitable? Pharming Group has a net margin of -6.09% compared to Twist Bioscience's net margin of -59.76%. Pharming Group's return on equity of -7.65% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Pharming Group-6.09% -7.65% -3.82% Twist Bioscience -59.76%-32.69%-25.25% Which has preferable valuation and earnings, PHAR or TWST? Pharming Group has higher earnings, but lower revenue than Twist Bioscience. Pharming Group is trading at a lower price-to-earnings ratio than Twist Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPharming Group$297.20M1.94-$10.55M-$0.17-49.94Twist Bioscience$330.19M7.02-$208.73M-$3.38-11.50 Which has more volatility and risk, PHAR or TWST? Pharming Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500. Does the MarketBeat Community believe in PHAR or TWST? Twist Bioscience received 82 more outperform votes than Pharming Group when rated by MarketBeat users. However, 67.65% of users gave Pharming Group an outperform vote while only 58.99% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformPharming GroupOutperform Votes2367.65% Underperform Votes1132.35% Twist BioscienceOutperform Votes10558.99% Underperform Votes7341.01% Do analysts rate PHAR or TWST? Pharming Group currently has a consensus target price of $30.00, indicating a potential upside of 253.36%. Twist Bioscience has a consensus target price of $52.80, indicating a potential upside of 35.80%. Given Pharming Group's stronger consensus rating and higher possible upside, analysts clearly believe Pharming Group is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pharming Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Does the media prefer PHAR or TWST? In the previous week, Twist Bioscience had 3 more articles in the media than Pharming Group. MarketBeat recorded 8 mentions for Twist Bioscience and 5 mentions for Pharming Group. Twist Bioscience's average media sentiment score of 1.10 beat Pharming Group's score of 0.83 indicating that Twist Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pharming Group 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in PHAR or TWST? 0.0% of Pharming Group shares are held by institutional investors. 2.1% of Pharming Group shares are held by insiders. Comparatively, 3.0% of Twist Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryPharming Group and Twist Bioscience tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Pharming Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PHAR vs. The Competition Export to ExcelMetricPharming GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$577.58M$6.33B$5.32B$7.55BDividend YieldN/A3.20%5.11%4.34%P/E Ratio-32.656.7521.6217.70Price / Sales1.94225.79373.9693.31Price / Cash91.8265.6738.1534.64Price / Book2.605.806.383.95Net Income-$10.55M$141.32M$3.20B$247.24M7 Day Performance4.69%3.68%5.15%5.01%1 Month Performance-3.19%-14.02%-7.51%-6.50%1 Year Performance-19.37%-15.82%7.35%-2.61% Pharming Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PHARPharming Group2.5913 of 5 stars$8.00-0.6%$30.00+275.0%-24.0%$544.25M$297.20M-30.77280Short Interest ↓Gap UpTWSTTwist Bioscience3.4456 of 5 stars$36.99+2.2%$54.10+46.3%+29.8%$2.21B$330.19M-10.94990High Trading VolumeHCMHUTCHMED2.266 of 5 stars$12.14-15.6%$19.00+56.5%-16.7%$2.12B$630.20M0.001,988Gap UpMIRMMirum Pharmaceuticals3.9749 of 5 stars$41.00-2.5%$58.20+42.0%+61.1%$2.01B$336.89M-20.30140Positive NewsVCELVericel2.402 of 5 stars$39.90-4.8%$62.29+56.1%-13.9%$2.00B$237.22M665.11300Analyst ForecastInsider TradeNews CoverageGap UpHigh Trading VolumeBHCBausch Health Companies4.001 of 5 stars$5.26-1.4%$7.17+36.4%-50.6%$1.93B$9.63B-43.7919,900Short Interest ↑Positive NewsGap DownBHVNBiohaven3.5123 of 5 stars$17.86-3.9%$62.77+251.4%-65.2%$1.82BN/A-1.91239Gap UpTARSTarsus Pharmaceuticals2.9398 of 5 stars$47.49+1.0%$63.67+34.1%+34.7%$1.82B$182.95M-12.4650Positive NewsGMTXGemini TherapeuticsN/A$41.22-9.9%N/A+21.7%$1.79BN/A-41.2230High Trading VolumeAAPGAscentage Pharma Group InternationalN/A$20.40-2.6%N/AN/A$1.78B$980.65M0.00600Positive NewsGap UpBLTEBelite Bio2.8501 of 5 stars$55.67-2.2%$96.67+73.6%+58.8%$1.77BN/A-50.1510Short Interest ↓Gap Up Remove Ads Related Companies and Tools Related Companies TWST Competitors HCM Competitors MIRM Competitors VCEL Competitors BHC Competitors BHVN Competitors TARS Competitors GMTX Competitors AAPG Competitors BLTE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PHAR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
